• 제목/요약/키워드: Rheumatoid Factor

검색결과 191건 처리시간 0.033초

Response to Bee Venom Acupuncture and Polymorphism of Interleukin 4 Receptor and Interleukin 10 in Rheumatoid Arthritis

  • Kim, Yung-Tae;Lee, Jae-Dong;Lee, Yun-Ho
    • 대한한의학회지
    • /
    • 제25권2호
    • /
    • pp.207-219
    • /
    • 2004
  • Objectives : We investigated to find the relationship between single-nucleotide polymorphism (SNP) of IL4R, IL-10 and bee venom therapy efficacy in patients with RA treated with bee venom for 8 weeks. Methods : Korean RA patients (n=114) and healthy subjects (n=109) were included in this prospective study. Korean bee venom was dissolved in saline (diluted 1:3000) and administrated into acupuncture points. Bee venom therapy was applied twice a week and continued for 8 weeks. The clinical response was evaluated using various assessments before and after treatment. Disease severity was measured by determining the number of tender joints and swollen joints. Laboratory studies included ESR, CRP, and rheumatoid factor. Genotyping for IL-4R and IL-10 polymorphism was done by pyrosequencing analysis. Results : 1. In IL4R genotypes, there was significant difference between RA ptitients tind controls group. 2. In IL4R genotypes, there was significant difference among Good, Mild and Bad responders to in RA patients, but in the frequency of alleles and carriers, there were no significant difference. 3. There was no significant difference between RA patients and controls group in IL-10 gene genotypes. 4. In IL-10 genotypes, there was no significant difference among Good, Mild and Bad responders to in RA patients. 5. There was no significant difference in the improvement of ESR, CRP and KHAQ scores after bee venom therapy in RA patients among the IL4R or IL-10 genotypes. Conclusions : In IL-4R genotypes, there was significant difference between RA patients and control group, and among Good, Mild and Bad responders in RA patients. However, in IL-10 genotypes, there was no significant difference between RA patients and controls group and among Good, Mild and Bad responders in RA patients.

  • PDF

만성 관절염 환자의 사회적 지지가 우울, 자아존중감에 미치는 영향 (Influence of the Social Support on their Mental Health of the Rheumatoid Arthritis Patients)

  • 이선옥
    • 한국간호교육학회지
    • /
    • 제9권2호
    • /
    • pp.253-263
    • /
    • 2003
  • Rheumatoid arthritis patients not only suffer from the physical damage, but they are afflicted severely mental and psychologic after effects. Their depression and low self-esteem eventually yields serious mental damages, which makes difficult for them to recover. The states of mental health of arthritis patients are diversified depending on the characters and surrounding circumstances, although they may have suffered from the similar condition. Therefore this research was conbucted to the factors that can give positive influences to the patients. In recent time, social support for the arthritis patients has become an important factor that can positively influence their mental health. In other words, social support can act as an important environmental system for arthritis patients to recover their damaged mental health. In order to fulfill this purpose, 118 patients were examined to identify the relationship between the variables. The summary of the result obtained from the research is as follow: 1. The structural aspect of social support for arthritis patients showed the most of them had various social support network size and their highest support system were 'family', 'relative' and 'friends'. The functional aspect of social support for arthritis patients showed moderate degree and their highest sub component was 'approval'. 2. High correlation was found between duration of relationship, similarity, frequency of meeting and functional support. There was no relationship between depression, self-esteem and social support. 3. Therefore this research has suggested that nurses who care rheumatoid arthritis patient consider the above condition to develop self-help group.

  • PDF

류마티스 관절염을 가진 만성신질환 환자에서 저용량 methotrexate 투여 후 발생한 중증 범혈구 감소증 2예 (Two Cases of Severe Pancytopenia Associated with Low-Dose Methotrexate Therapy in Patients with Chronic Kidney Disease and Rheumatoid Arthritis)

  • 김홍익;이우현;오장석;홍효림;이인희
    • Journal of Yeungnam Medical Science
    • /
    • 제28권1호
    • /
    • pp.60-69
    • /
    • 2011
  • Due to its efficacy and tolerability, low dose oral methotrexate (MTX) therapy has been widely used for treatment of rheumatoid arthritis (RA). However, it can rarely cause serious, life-threatening hematologic toxicities, such as pancytopenia. We report here on two patients with chronic kidney disease (CKD), who developed severe pancytopenia after 5 years (cumulative dose 1,240 mg) and 4 years (cumulative dose 1,320 mg) of low dose MTX therapy for treatment of RA, respectively. Both patients presented with renal insufficiency, hypoalbuminemia, concurrent use of nonsteroidal anti-inflammatory drugs, and elevated mean corpuscular volume of red blood cells (RECs), all of which are known as risk factors of MTX-induced pancytopenia. Despite receiving treatment, which included REC and platelet transfusions, antibiotic therapy, granulocyte colony stimulating factor, and leucovorin rescue, one patient died of sepsis. Based on our case study, prompt investigation of risk factors associated with MTX toxicity is required for all patients receiving MTX therapy. MTX treatment, even at a low dose, should be discontinued in patients with advanced CKD.

  • PDF

관절9호방이 생쥐의 Collagen II 유발 관절염에 미치는 영향 (Inhibitory Effects of Gwanjul9-bang on Collagen Induced Arthritis in DBA/1J Mouse)

  • 김은혜;오민석
    • 동의생리병리학회지
    • /
    • 제24권3호
    • /
    • pp.490-503
    • /
    • 2010
  • This study was carried out to know the effects of Gwanjul9-bang (hereinafter reffered to GJ9) on the inhibition of arthritis induced by collagen on DBA/1J mouse. For this purpose, GJ9 was orally administered to mouse with arthritis induced by collagen II. Cytotoxicity, hepatotoxicity, arthritis index, value of immunocyte in draining lymph node and paw joint, rheumatoid factor (IgG, IgM) in serum were measured in vivo. The cytotoxicity against hFCs was not measured in any concentration. The hepatotoxicity was low in GJ9 treated group compared with MTX group. The arthritis index was decreased significantly. In total cell counts of DLN and paw joint, the cells in DLN increased significantly while there was significantly decrease in paw joint. In lymph nodes, $CD19^+$, $CD3^+$, $CD4^+$, $CD3^+CD69^+$, $CD8^+$, $CD4^+CD25^+$, $CD3^+CD49b^+$, $CD4^+CD44^+$, $CD3^+CD8^+$ cells increased significantly, $B220^+CD23^+$cells decreased significantly. In joints, $CD3^+$, $CD4^+$, $CD4^+CD25^+$, $CD11b^+Gr-1^+$ cells decreased significantly. The levels of IgG and IgM was significantly decreased compared with control. Anti-collagen II in serum was significantly decreased compared with control. The degree of arthritis induced damage of joint of GJ9 group is slight compared with control group in histopathologic observation (Hematoxylin & Eosin, Masson's Trichrome). Comparison of the results for this study showed that GJ9 had immunomodulatory effects. So we expect that GJ9 should be used as a effective drugs for not only rheumatoid arthritis but also another auto-immune disease. Therefore we have to survey continuously in looking for the effective substance and mechanism in the future.

The Protective Effect of Chondroitin from Raja kenojei Cartilage on Collagen-induced Arthritis in DBA/1J Mice

  • Jin, Cheng-Hao;Yang, Ung;Kim, Song-Hee;Ryu, Jae-Won;Lee, Jae-Chang;Lee, Dong-Seok;Lee, Tae-Hoon
    • Food Science and Biotechnology
    • /
    • 제16권4호
    • /
    • pp.594-599
    • /
    • 2007
  • In this study, we evaluated whether the oral administration of chondroitin from the cartilage of Raja kenojei is effective on the progression of rheumatoid arthritis (RA), using collagen-induced arthritic (CIA) mice. Arthritis development was delayed dose-dependently in the chondroitin-treated groups. The pre- and late-treated groups receiving 1,000 mg/kg of chondroitin had clinical scores that were reduced significantly by 56.9 (p<0.05) and 43.3% (p<0.05), respectively, compared to the vehicle-treated groups. Hematoxylin eosin staining and X-ray radiography showed that the chondroitins reduced the infiltration of inflammatory cells and prevented joint destruction of the knee and paw. Reverse transcription-polyerase chain reaction analysis revealed that chondroitin administration inhibited the expressions of tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$), $interlukin-1{\beta}$ ($IL-1{\beta}$), and $interferon-{\gamma}$ ($IFN-{\gamma}$) in joints more than the administration of vehicle. Chondroitin treatment also decreased the production of rheumatoid factors (RF), IgG and IgM, in the serum of CIA mice. These results indicate that chrondroitin administration has a protective effect involving the inhibition of pro-inflammatory cytokine production in CIA mice.

창출도인탕가미방(蒼朮桃仁湯加味方)이 DBA/1J 생쥐의 collagen 유발 관절염 억제에 미치는 영향 (Inhibitory Effects of Changchuldoin-tanggamibang on Collagen Induced Arthritis in DBA/1J Mouse)

  • 박장우;오민석
    • 대한한의학회지
    • /
    • 제31권2호
    • /
    • pp.19-35
    • /
    • 2010
  • Objectives: This study was carried out to find the effects of Changchuldoin-tanggamibang (hereinafter referred to CDIT) on the inhibition of arthritis induced by collagen on DBA/1J mouse. Methods: The experimental mice were divided into four groups: normal group (Nr), control group (CIA-CT), methotrexate group (CIA-MTX), and Changchuldoin-tanggamibang group (CIA-CDIT). Cytotoxicity, hepatotoxicity, arthritis index, value of immunocytes in draining lymph node and paw joint, and rheumatoid factor (IgG, IgM) in serum were measured in vivo. Results: 1. Cytotoxicity against hFCs was not shown in any concentration. 2. Hepatotoxicity was low in the CDIT-treated group compared with the MTX group. 3. The arthritis index decreased significantly. 4. In total cell counts of DLN and paw joint, the cells in DLN increased significantly while there was a significant decrease in paw joint. 5. In lymph nodes, CD19+, CD3+, CD4+, CD8+, CD3+/CD8+, CD3+/CD69+, CD4+/CD25+, CD3+/CD49b+, and CD4+/CD44+ cells increased significantly, while B220+/CD23+, and CD11c+/MHCII+ cells decreased significantly. 6. In joints, CD3+, CD4+, CD4+/CD25+, and CD11b+/Gr-1+ cells decreased significantly. 7. The level of IgG decreased and the level of IgM significantly decreased compared with the control. 8. Anti-collagen II in serum decreased compared with the control. 9. Around the joint of the CDIT group, infiltration of inflammation, synovial hyperplasia, invasion of cytokine, of cartilage, deposition of collagen and synovial injury decreased compared with the control in histopathologic observation (HE, MT staining). Conclusions: Comparison of the results for this study showed that CDIT had immunomodulatory effects. We expect that CDIT could be used as a effective drug for not only rheumatoid arthritis but also another auto-immune diseases. Therefore, we have to survey continuously, looking for effective substances and mechanisms in the future.

Long-term treatment of allogeneic adipose-derived stem cells in a dog with rheumatoid arthritis

  • Seo, Min-Gyeong;Park, Seil;Han, Seonyoung;Kim, Ah-Young;Lee, Eun-Joo;Jeong, Kyu-Shik;Hong, Il-Hwa
    • Journal of Veterinary Science
    • /
    • 제23권4호
    • /
    • pp.61.1-61.10
    • /
    • 2022
  • Background: Although there are growing demands for stem cell-based therapy for companion animals in various diseases, a few clinical trials have been reported. Moreover, most of them are the results from only one or a few times of stem cell injection. Objectives: The aim of this study is to describe a long-term treatment with allogeneic adipose-derived stem cells (ASCs) in a dog with rheumatoid arthritis (RA), which is a rare canine disease. Methods: The dog with RA received intravascular injection of allogeneic ASCs derived from two healthy donors once a month for 11 months. To assess therapeutic effects of ASCs, orthopedic examination and clinical evaluation was performed. Cytokines of tumor necrosis factor-α and interleukin-6 in the plasma were measured using ELISA analysis. Results: Despite this repeated and long-term administration of allogeneic ASCs, there were no side effects such as immunorejection responses or cell toxicity. The orthopedic examination score for the dog decreased after ASCs treatment, and the clinical condition of the dog and owner's satisfaction were very good Conclusions: Although ASCs has been suggested as one of the options for RA treatment because of its anti-inflammatory and immunosuppressive functions, it has never been used to treat RA in dogs. The present report describes a case of canine RA treated with allogeneic ASCs for long-term in which the dog showed clinical improvement without adverse effects.

Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research

  • Mingyo Kim;Yong-ho Choe;Sang-il Lee
    • IMMUNE NETWORK
    • /
    • 제22권1호
    • /
    • pp.8.1-8.20
    • /
    • 2022
  • Rheumatoid arthritis (RA) is a representative autoimmune disease that is primarily characterized by persistent inflammation and progressive destruction of synovial joints. RA has a complex and heterogeneous pathophysiology, involving interactions among various immune and joint stromal cells and a diverse network of cytokines and intracellular signaling pathways. With improved understanding of RA, over the past decades, therapeutic strategies have become considerably advanced and now included targeted molecular therapies, such as tumor necrosis factor inhibitors, IL-6 blockers, B-cell depletion agents, as well as inhibitors of T-cell co-stimulation and Janus kinases. However, a considerable proportion of RA patients experience refractory disease and interrupted treatment owing to the associated risk of developing serious infections and cancers. In contrast, although IL-1β, IL-17A, and p38α play significant roles in RA pathogenesis, several drugs targeting these factors have not been approved because of their low efficacy and severe adverse effects. In this review, we provide an overview of the working mechanism, advantages, and limitations of the currently available targeted drugs for RA. Additionally, we suggest potential mechanistic causes for clinically approved and failed drugs. Thus, this review provides perspectives on approaches for basic and translational studies that hold promise for identifying future next-generation therapeutics for RA.

오디추출물 투여가 류머티즘 요인이 있는 일부 한국 중년여성의 혈중 항산화 및 항염증 관련 지표수준에 미치는 영향 (The Effects of Mulberry Extract Consumption on the Serum Levels of Oxidant and Inflammatory Factors in Middle-aged Women with Rheumatoid Factors)

  • 신정희;한세미;김애정
    • 한국산학기술학회논문지
    • /
    • 제13권8호
    • /
    • pp.3561-3569
    • /
    • 2012
  • 본 연구의 목적은 오디가 류머티스 요인(Rheumatoid Factor: RF>10 u/mL)이 있는 중년여성의 혈중 항산화 및 항염증 지표수준에 미치는 영향을 알아보고자 32명의 중년여성을 2군 (NMG, AMG)으로 나누어 4주간의 오디 추출물 투여 전ㆍ후로 체성분 측정 및 채혈을 통하여 혈청 산화(TBARS, FRAP) 및 염증성 지표물질(요산, C-reactive protein: CRP, RF 및 homocystein) 농도를 분석 및 비교하였다. 연구결과 오디 추출물 투여에 따른 NMG와 AMG간의 체성분에는 차이가 없었다. AMG의 CRP 수준은 $0.80{\pm}0.05$ mg/dL에서 $0.55{\pm}0.02$ mg/dL로 유의적으로 감소하였다(p<0.05). AMG의 오디 추출물 투여 전의 혈청 TBARS 수준($63.04{\pm}12.20$ mol/L)은 투여 후($57.44{\pm}11.16$ mol)와 유의적인 차이는 없었으나, 감소하는 경향을 보였다. AMG의 혈청 FRAP 수준은 급여 전($1239.02{\pm}63.22$ mol)에 비해 급여 후($1556.21{\pm}11.16$ mol) 유의적으로 증가되었다(p<0.05). AMG의 혈청 TNF-${\alpha}$$8.78{\pm}0.12$ pg/mL에서 $6.58{\pm}0.16$ pg/mL로, IL-2 수준은 $5.41{\pm}0.71$ pg/mL에서 $3.94{\pm}0.03$ pg/mL로, IL-4 수준은 $7.21{\pm}0.61$ pg/mL에서 $5.15{\pm}0.36$ pg/mL로 감소하여 오디 추출물 투여에 의한 항산화 및 항염증 활성이 규명되었다. 이상의 연구결과로 볼 때 오디는 류머티즘 요인이 있는 중년여성의 항산화 및 항염증 활성을 강화시키는데 도움이 된 것으로 보인다. 따라서 산화 스트레스 감소를 통한 염증조절물질로써 오디를 꾸준히 섭취한다면 류머티스 관절염(Rheumatoid Arthiritis: RA)환자의 질병관리에 부작용 없이 도움이 될 것으로 사료된다. 본 연구를 기초로 후속적으로 RA 발병 유발인자인 사이토카인을 효과적으로 통제할 수 있는 오디를 활용한 치료식 개발 및 보급을 활성화하여 국내 오디 농가의 부가가치 창출에도 기여할 수 있을 것으로 기대된다.

Idiopathic Pleuroparenchymal Fibroelastosis Presenting in Recurrent Pneumothorax: A Case Report

  • Noh, Hyun Jin;Seo, Yun;Huo, Sol Mi;Kim, Tae Jung;Kim, Hyo Lim;Song, Jeong Sup
    • Tuberculosis and Respiratory Diseases
    • /
    • 제77권4호
    • /
    • pp.184-187
    • /
    • 2014
  • Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a rare, recently classified entity that consists of pleural and subjacent parenchymal fibrosis predominantly in the upper lungs. In an official American Thoracic Society/European Respiratory Society statement in 2013, this disease is introduced as a group of rare idiopathic interstitial pneumonias. We describe a case of a 76-year-old woman with cough and recurrent pneumothorax. She was admitted to our hospital with severe cough at first. High resolution computed tomography (HRCT) disclosed multifocal subpleural consolidations with reticular opacities in both lungs, primarily in the upper lobes, suggesting interstitial pneumonia. Rheumatoid lung was diagnosed initially through an elevated rheumatoid factor, HRCT and surgical biopsy at the right lower lobe. However, one month later, pneumothorax recurred. Surgical biopsy was performed at the right upper lobe at this time. The specimens revealed typical subpleural fibroelastosis. We report this as a first case of idiopathic PPFE in Korea after reviewing the symptoms, imaging and pathologic findings.